Inactive Instrument

Taro Pharmaceutical Industries Ltd. Stock

Equities

TARO

IL0010827181

Pharmaceuticals

Delayed Nyse 04:00:02 2024-06-21 pm EDT 5-day change 1st Jan Change
42.97 USD -.--% Intraday chart for Taro Pharmaceutical Industries Ltd. -.--% +2.85%
Dynamic Chart
Taro Pharmaceutical Industries Ltd.(NYSE:TARO) dropped from S&P Global BMI Index CI
Sun Pharmaceutical Industries Limited acquired remaining 21.5% stake in Taro Pharmaceutical Industries Ltd. from Krensavage Asset Management, LLC and others for approximately CI
Taro Pharmaceutical's Shareholders Approve Merger With Sun Pharmaceutical MT
Transcript : Taro Pharmaceutical Industries Ltd. - Shareholder/Analyst Call
Transcript : Taro Pharmaceutical Industries Ltd. - Shareholder/Analyst Call
Taro Pharmaceutical Industries Fiscal Q4 Earnings, Revenue Rise MT
Earnings Flash (TARO) TARO PHARMACEUTICAL INDUSTRIES Reports Q4 Revenue $164.9M, vs. Street Est of $156.1M MT
Taro Pharmaceutical Industries Ltd. Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Taro Pharmaceutical Industries Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Taro Pharmaceutical Industries Fiscal Q3 Net Income, Net Sales Rise; Shares Climb After Hours MT
Taro Pharmaceutical Industries Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
HC Wainwright Downgrades Taro Pharmaceutical Industries to Neutral From Buy, $43 Price Target MT
India's Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 mln RE
Taro Pharmaceutical to go Private in Merger Deal With Sun Pharmaceutical MT
Sun Pharmaceutical to Take Taro Private at $43/Share DJ
More news

Latest transcript on Taro Pharmaceutical Industries Ltd.

Managers TitleAgeSince
Chief Executive Officer 54 16-11-30
Director of Finance/CFO 69 07-12-31
Chief Tech/Sci/R&D Officer 58 -
Members of the board TitleAgeSince
Director/Board Member 73 20-01-31
Chairman 68 10-09-21
Director/Board Member 67 10-08-31
More insiders
Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical products in over 25 countries. The Company's owned product brands include Rokacet, with generic names, such as acetaminophen, codeine and caffeine; Topicort, with the generic name, desoximetasone; Etopan, with the generic name etodolac, and Ovide, with the generic name, malathion, among others. The Company's other generic products include acetazolamide, adapalene, alclometasone dipropionate, amiodarone hydrochloride, ammonium lactate, augmented betamethasone dipropionate, cetirizine hydrochloride, clobetasol propionate, clomipramine hydrochloride, clorazepate dipotassium, fluorouracil, ketoconazole, metronidazole, mupirocin and warfarin sodium, among others.
Related indices
More about the company